Dianthus Therapeutics | MGTA - Capitaux D'Emprunt

Prix De L'Action
77.76
Variation Quotidienne
-2.24 -2.80%
Mensuellement
47.61%
Annuel
298.97%
Q1 Prévisions
75.43




Capitaux D'Emprunt Changement Date
Akebia Therapeutics USD 48.25M 609K 2025-12
Alaunos Therapeutics USD 4.47M 5.85M 2022-06
Avita Medical AUD 42.24M 1.25M 2024-12
Celltrion KRW 63.29B 4.01B 2025-09
Cspc Pharmaceutical CNY 158.75M 102.62M 2025-06
Deva Holding AS TRY 559.97M 44.39M 2023-09
Dianthus Therapeutics USD 0 0 2024-12
Divis Laboratories Ltd INR 20M 0 2025-03
IQVIA Holdings USD 13.88B 1.09B 2025-12
Kangmei Pharma CNY 78.45M 5.8M 2025-09
Knight Therapeutics CAD 57.78M 26.92M 2025-12
Laboratorios Farma EUR 80.5M 28.26M 2024-12
Malin Corporation EUR 0 0 2024-12
Medical Developments International AUD 1.5M 167K 2025-12
Moderna USD 610M 584M 2025-12
Organigram Holdings CAD 62.52M 13.88M 2025-12
Organon & Co USD 8.78B 117M 2025-09
Ovoca Bio EUR 0 0 2021-06
Pharma Mar EUR 36.68M 1.07M 2025-12
Qiagen NV USD 1.65B 15.23M 2025-12
Revvity USD 2.63B 543K 2025-12
Sartorius EUR 3.41B 682.5M 2025-09
Sino Biopharmaceutical CNY 3.08B 1B 2025-06
Tectonic Therapeutic USD 43K 57K 2025-12
Tilray USD 268.59M 3.82M 2025-09
Viatris USD 12.48B 7M 2025-12
Xeris Pharmaceuticals USD 220.33M 866K 2025-12
Zealand Pharma A/S 383.14M 727K 2025-12
Zz Pientze Pharmaceu CNY 186.56M 9.75M 2025-09